Business Description
BioLife Solutions Inc
NAICS : 339113
SIC : 3841
ISIN : US09062W2044
Description
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.87 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -1.04 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 11.9 | |||||
| Beneish M-Score | -3.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23 | |||||
| 3-Year EPS without NRI Growth Rate | -118.2 | |||||
| 3-Year Book Growth Rate | 6.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.86 | |||||
| 9-Day RSI | 52.18 | |||||
| 14-Day RSI | 53.49 | |||||
| 6-1 Month Momentum % | 14.59 | |||||
| 12-1 Month Momentum % | 48.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.78 | |||||
| Quick Ratio | 1.78 | |||||
| Cash Ratio | 1.06 | |||||
| Days Inventory | 144.58 | |||||
| Days Sales Outstanding | 46.98 | |||||
| Days Payable | 23.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11 | |||||
| Shareholder Yield % | 0.34 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 35.22 | |||||
| Operating Margin % | -28.69 | |||||
| Net Margin % | -30.3 | |||||
| FCF Margin % | 3.72 | |||||
| ROE % | -13.95 | |||||
| ROA % | -11.61 | |||||
| ROIC % | -12.87 | |||||
| ROC (Joel Greenblatt) % | -67.06 | |||||
| ROCE % | -13.1 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.89 | |||||
| PB Ratio | 3.75 | |||||
| Price-to-Tangible-Book | 14.79 | |||||
| Price-to-Free-Cash-Flow | 214.47 | |||||
| Price-to-Operating-Cash-Flow | 133.23 | |||||
| EV-to-EBIT | -25.89 | |||||
| EV-to-EBITDA | -32.32 | |||||
| EV-to-Revenue | 8.02 | |||||
| EV-to-Forward-Revenue | 11.82 | |||||
| EV-to-FCF | 225.57 | |||||
| Price-to-Projected-FCF | 7.62 | |||||
| Price-to-Median-PS-Value | 1.15 | |||||
| Price-to-Net-Current-Asset-Value | 36.76 | |||||
| Earnings Yield (Greenblatt) % | -3.86 | |||||
| FCF Yield % | 0.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioLife Solutions Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 139.243 | ||
| EPS (TTM) (€) | -0.931 | ||
| Beta | 1 | ||
| Volatility % | 39.03 | ||
| 14-Day RSI | 53.49 | ||
| 14-Day ATR (€) | 0.654521 | ||
| 20-Day SMA (€) | 25.13 | ||
| 12-1 Month Momentum % | 48.25 | ||
| 52-Week Range (€) | 13.9 - 26 | ||
| Shares Outstanding (Mil) | 46.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioLife Solutions Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioLife Solutions Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioLife Solutions Inc Frequently Asked Questions
What is BioLife Solutions Inc(FRA:BJX1)'s stock price today?
The current price of FRA:BJX1 is €25.00. The 52 week high of FRA:BJX1 is €26.00 and 52 week low is €13.90.
When is next earnings date of BioLife Solutions Inc(FRA:BJX1)?
The next earnings date of BioLife Solutions Inc(FRA:BJX1) is 2025-02-28 Est..
Does BioLife Solutions Inc(FRA:BJX1) pay dividends? If so, how much?
BioLife Solutions Inc(FRA:BJX1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers